Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin and Duloxetine for Neuropathic Pain in TKA
NCT05254652Unknown
- Sponsor
- The Catholic University of Korea
- Start
- May 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pregabalin in neuropathic pain (2 arms), sponsored by The Catholic University of Korea. Primary endpoint: Visual Pain Scale change at 1 year. Status: unknown.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT05254652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05254652.